Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1273)

  • Rodriguez-Temporal, D; Alcaide, F; Marekovic, I; O'Connor, JA; Gorton, R; van Ingen, J; Van den Bossche, A; Hery-Arnaud, G; Beauruelle, C; Orth-Holler, D; Palacios-Gutierrez, JJ; Tudo, G; Bou, G; Ceyssens, PJ; Garrigo, M; Gonzalez-Martin, J; Greub, G; Hrabak, J; Ingebretsen, A; Mediavilla-Gradolph, MC; Oviano, M; Palop, B; Pranada, AB; Quiroga, L; Ruiz-Serrano, MJ; Rodriguez-Sanchez, B.

    Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification

    Scientific Reports. 2022; 12(1): Nº de citas: 31 [doi:10.1038/s41598-022-05315-7]

  • Rodriguez-Grande, C; Alcala, L; Estevez, A; Sola-Campoy, PJ; Buenestado-Serrano, S; Martinez-Laperche, C; de la Cueva, VM; Alonso, R; Andres-Zayas, C; Adan-Jimenez, J; Losada, C; Rico-Luna, C; Comas, I; Gonzalez-Candelas, F; Catalan, P; Munoz, P; Perez-Lago, L; de Viedma, DG; Gregorio Maranon Microbiol-ID COVI.

    Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

    EMERGING INFECTIOUS DISEASES. 2022; 28(1): 85-94 Nº de citas: 13 [doi:10.3201/eid2801.211952]

  • Pérez-Granda MJ; Carrillo CS; Rabadán PM; Valerio M; Olmedo M; Muñoz P; Bouza E.

    Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control

    Journal of Hospital Infection. 2022; 119: 149-154 Nº de citas: 42 [doi:10.1016/j.jhin.2021.09.020]

  • Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M.

    Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study

    JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1): Nº de citas: 41 [doi:10.1128/JCM.01689-21]

  • Palacios-Mendoza, M; Gomez, A; Prieto, J; Barrios, JC; Orera, M; Massot-Tarrus, A.

    Response to anakinra in new-onset refractory status epilepticus: A clinical case

    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2022; 94: 92-94 Nº de citas: 8 [doi:10.1016/j.seizure.2021.11.014]

  • Mesquida, A; Diaz-Garcia, J; Sanchez-Carrillo, C; Munoz, P; Escribano, P; Guinea, J.

    In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method

    CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(1): Nº de citas: 22 [doi:10.1016/j.cmi.2021.09.030]

  • Munoz, P; De la Villa, S; Martinez-Selles, M; Goenaga, MA; Reviejo-Jaka, K; de las Revillas, FA; Garcia-Cuello, L; Hidalgo-Tenorio, C; Rodriguez-Esteban, MA; Antorrena, I; Castelo-Corral, L; Garcia-Vazquez, E; De la Torre, J; Bouza, E; Grp Apoyo Manejo Endocarditis Infe.

    Linezolid for infective endocarditis A structured approach based on a national database experience

    MEDICINE. 2021; 100(51): Nº de citas: 6 [doi:10.1097/MD.0000000000027597]

  • Guinea J; Mezquita S; Gómez A; Padilla B; Zamora E; Sánchez-Luna M; Sánchez-Carrillo C; Muñoz P; Escribano P.

    Whole genome sequencing confirms Candida albicans and Candida parapsilosis microsatellite sporadic and persistent clones causing outbreaks of candidemia in neonates

    MEDICAL MYCOLOGY. 2021; 60(1): Nº de citas: 27 [doi:10.1093/mmy/myab068]

  • Serrano-Lobo J; Gómez A; Muñoz P; Escribano P; Guinea J.

    Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are >= 90 and >= 95% fungal growth inhibition endpoints equally suitable?

    MEDICAL MYCOLOGY. 2021; 60(1): Nº de citas: 6 [doi:10.1093/mmy/myab072]

  • Bouza, E; Jimenez, MM; Alemany, L; Arribas, J; Banares, R; Barragan, MB; Bouza, JME; Felip, E; Fernandez-Capetillo, O; Gracia, D; Lopez-Velez, R; Mollar, JB; Munoz, P; Paz-Ares, L; Torne, A; Tovar, J; Valencia, E; Palomo, E.

    Overview of virus and cancer relationships. Position paper

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2021; 34(6): 525-555 Nº de citas: 7 [doi:10.37201/req/058.2021]

  • Vicent, L; Bruna, V; Devesa, C; Sousa-Casasnovas, I; Juarez, M; Alcala, L; Munoz, P; Fernandez-Aviles, F; Martinez-Selles, M.

    Ticagrelor and Infection Risk in Patients with Coronary Artery Disease

    CARDIOLOGY. 2021; 146(6): 698-704 Nº de citas: 6 [doi:10.1159/000519285]

  • Bouza, E; Munoz, P; Burillo, A.

    Gram-negative endocarditis: disease presentation, diagnosis and treatment

    CURRENT OPINION IN INFECTIOUS DISEASES. 2021; 34(6): 672-680 Nº de citas: 18 [doi:10.1097/QCO.0000000000000788]

  • van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ; Guideline Committee of the European Study Group on Clostridioides difficile.

    European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

    CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27: 1-21 Nº de citas: 449 [doi:10.1016/j.cmi.2021.09.038]

  • Peghin, M; Bouza, E; Fabris, M; De Martino, M; Palese, A; Bontempo, G; Graziano, E; Gerussi, V; Bressan, V; Sartor, A; Isola, M; Tascini, C; Curcio, F.

    Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2021; 40(12): 2597-2604 Nº de citas: 16 [doi:10.1007/s10096-021-04335-x]

  • Gomez-Zorrilla, S; Becerra-Aparicio, F; Montesinos, IL; de Gopegui, ER; Grau, I; Pintado, V; Padilla, B; Benito, N; Boix-Palop, L; Farinas, MC; Penaranda, M; Gamallo, MR; Martinez, JA; Morte-Romea, E; Del Pozo, JL; Duran-Jorda, X; Diaz-Reganon, J; Lopez-Mendoza, D; Canton, R; Oliver, A; Ruiz-Garbajosa, P; Horcajada, JP.

    A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    Infectious Diseases and Therapy. 2021; 10(4): 2677-2699 Nº de citas: 10 [doi:10.1007/s40121-021-00537-0]

  • Brito-Zeron, P; Perez-Alvarez, R; Feijoo-Masso, C; Gracia-Tello, B; Gonzalez-Garcia, A; Gomez-de-la-Torre, R; Alguacil, A; Lopez-Dupla, M; Robles, A; Garcia-Morillo, S; Bonet, M; Cruz-Caparros, G; Fonseca-Aizpuru, E; Akasbi, M; Callejas, JL; de Miguel-Campo, B; Perez-de-Lis, M; Ramos-Casals, M; De-Escalante, B; Chara-Cervantes, J; Perez-Conesa, M; Rascon, J; Pallares; Perez-Guerrero, P; De-la-Red, G; Calvo, E; Soler, C; Peral-Gutierrez, E; Gomez-Cerezo, JF; Rodriguez-Fernandez, S; Pinilla, B; Toledo-Samaniego, N; Gato, A; Chamorro, AJ; Morcillo, C; Ojeda, I; Vives, MJ; de-Miguel, B; Penades, M; De-Vicente, M; The SarcoGEAS-SEMI Registry.

    Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    JOINT BONE SPINE. 2021; 88(6): 105236-105236 Nº de citas: 29 [doi:10.1016/j.jbspin.2021.105236]

  • Reigadas, E; van Prehn, J; Falcone, M; Fitzpatrick, F; Vehreschild, MJGT; Kuijper, EJ; Bouza, E; European Soc Clinical Microbiology; Study Grp Host Microbiota Interact.

    How to: prophylactic interventions for prevention of Clostridioides difficile infection

    CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(12): 1777-1783 Nº de citas: 22 [doi:10.1016/j.cmi.2021.06.037]

  • Bouza, E.

    The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76: Nº de citas: 28 [doi:10.1093/jac/dkab353]